CINECA IRIS Institutional Research Information System

ROSSELLO, ARMANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.087
AS - Asia 11.020
EU - Europa 7.445
SA - Sud America 1.427
AF - Africa 381
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 10
Totale 39.390
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.483
SG - Singapore 3.099
CN - Cina 2.786
HK - Hong Kong 2.629
IT - Italia 2.392
BR - Brasile 1.181
SE - Svezia 1.175
DE - Germania 948
VN - Vietnam 702
BG - Bulgaria 638
GB - Regno Unito 473
TR - Turchia 472
FR - Francia 464
CA - Canada 451
FI - Finlandia 333
IN - India 303
RU - Federazione Russa 268
UA - Ucraina 263
JP - Giappone 229
KR - Corea 219
SN - Senegal 113
BD - Bangladesh 100
CH - Svizzera 90
AR - Argentina 88
IQ - Iraq 81
MX - Messico 73
AT - Austria 72
ES - Italia 63
ID - Indonesia 60
ZA - Sudafrica 54
PK - Pakistan 51
SA - Arabia Saudita 47
BE - Belgio 46
NL - Olanda 43
NG - Nigeria 42
EC - Ecuador 37
CI - Costa d'Avorio 34
VE - Venezuela 34
PL - Polonia 33
CO - Colombia 29
UZ - Uzbekistan 28
KE - Kenya 24
MA - Marocco 24
GR - Grecia 23
EG - Egitto 21
IE - Irlanda 19
AE - Emirati Arabi Uniti 18
MY - Malesia 17
PH - Filippine 17
JM - Giamaica 16
JO - Giordania 16
CL - Cile 15
TT - Trinidad e Tobago 15
TW - Taiwan 15
CZ - Repubblica Ceca 14
KZ - Kazakistan 14
PY - Paraguay 14
TN - Tunisia 14
AU - Australia 13
DZ - Algeria 13
LT - Lituania 13
AZ - Azerbaigian 12
IL - Israele 12
IR - Iran 11
LB - Libano 11
NP - Nepal 11
PT - Portogallo 11
UY - Uruguay 11
AL - Albania 10
ET - Etiopia 10
OM - Oman 10
BO - Bolivia 9
DO - Repubblica Dominicana 9
PA - Panama 9
PE - Perù 9
PS - Palestinian Territory 9
DK - Danimarca 8
RS - Serbia 8
TH - Thailandia 8
BJ - Benin 7
BY - Bielorussia 7
CR - Costa Rica 7
KG - Kirghizistan 7
NZ - Nuova Zelanda 7
RO - Romania 7
AO - Angola 6
BB - Barbados 6
EU - Europa 5
HU - Ungheria 5
BH - Bahrain 4
BW - Botswana 4
HR - Croazia 4
KW - Kuwait 4
SY - Repubblica araba siriana 4
EE - Estonia 3
GT - Guatemala 3
PR - Porto Rico 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
Totale 39.340
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.607
Woodbridge 2.209
Singapore 1.807
Ashburn 1.745
Ann Arbor 1.689
Chandler 1.171
Houston 1.131
Fairfield 1.098
San Jose 979
Santa Clara 975
Dallas 738
Shanghai 654
Sofia 637
Milan 576
Beijing 542
Serra 541
Seattle 471
Wilmington 421
New York 419
Ottawa 360
Cambridge 332
Jacksonville 318
Boardman 317
Izmir 307
Princeton 294
Hefei 277
Los Angeles 276
Lawrence 243
Medford 216
Lauterbourg 214
Nanjing 205
Seoul 204
Tokyo 203
Des Moines 191
Florence 190
Ho Chi Minh City 167
Council Bluffs 165
London 151
Dong Ket 126
Istanbul 115
Dakar 113
Frankfurt am Main 106
São Paulo 106
Hanoi 103
Bremen 102
Redondo Beach 101
Dearborn 100
Buffalo 96
Pisa 91
Columbus 83
Nanchang 81
Munich 80
Bern 78
Helsinki 77
Rome 75
The Dalles 72
Redwood City 69
Marseille 60
Vienna 58
Pune 52
Boulder 51
San Diego 50
Rio de Janeiro 49
Hebei 48
Jüchen 45
Kunming 44
Ogden 44
Baghdad 43
Brussels 43
Nürnberg 41
Orem 41
Lagos 40
Lancaster 37
Pessac 36
Shenyang 36
Chicago 35
Lucca 35
Abidjan 34
Changsha 32
Chennai 31
Jakarta 31
Auburn Hills 30
Livorno 30
San Francisco 30
Belo Horizonte 29
Tianjin 29
Jiaxing 28
Johannesburg 28
Guangzhou 27
Norwalk 27
Nuremberg 27
Brasília 26
Haiphong 26
Phoenix 26
Tashkent 26
Toronto 26
Alessandria 25
Da Nang 25
Dhaka 25
Fuzhou 25
Totale 28.345
Salva come PNG Salva come JPEG
Nome #
Strategies to target ADAM17 in disease: From its discovery to the iRhom revolution 1.272
N-(aroyl)-N-(arylmethyloxy)-α-alanines: selective inhibitors of aldose reductase 253
X-ray analisis, theoretical studies and a-adrenergic biopharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanol and its morpholine analogue 238
Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds 233
X-Ray analysis, theoretical studies and alfa-adrenergic biopharmacological properties of 1-(2,5-dimethoxyphenyl)-2-aminoethanol and its morpholine analogue. 224
Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies 222
New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design,Synthesis, and Biopharmacological Properties 220
ADAMs and ADAMTs selective synthetic inhibitors 214
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization 214
Activation of carbonic anhydrases from human brain by amino alcohol oxime ethers: towards human carbonic anhydrase VII selective activators 211
Synthesis and antimicrobial properties of new cepham and penam derivatives with the carboxylic group in the "wrong" ß-configuration 208
Design and Synthesis of Ionic Liquid-Based Matrix Metalloproteinase Inhibitors (MMPIs): A Simple Approach to Increase Hydrophilicity and to Develop MMPI-Coated Gold Nanoparticles 208
The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells 206
3-[(aryl)(4-fluorobenzyloxy)methyl]piperidine derivatives: high-affinity ligands for the serotonin transporter 206
The [(Methyloxy)imino]methyl Moiety as a Bioisoster of Aryl. A Novel Class of Completely Aliphatic Beta-Adrenergic Receptor Antagonists 206
Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates 206
ADAM metalloproteinases as potential drug targets 204
Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide 202
Enantiopure 3-(arylmethylidene)aminoxy-2-methylpropionic acids: synthesis and antiinflammatory properties 201
Synthesis and α2-adrenergic activity of 2-[(methyleneamino)oxy]-N-(guanidino)ethaneimines. A bioisosteric replacement of the aryl of guanabenz-type benzylideneaminoguanidine α2-agonists with the [(methyleneamino)oxy]methyl moiety (MAOMM) 198
INHIBITORS OF ZINC PROTEASES THIOARYL SUBSTITUTED AND THEIR USE 198
Synthesis and antimicrobial properties of substituted 3-aminoxy-(E)-2-methoxyiminopropionyl penicillins and cephalosporins 197
Synthesis and cycloxygenase inhibitory properties of new naphthalene-methylsulfonamido, naphthalene-methylsulfonyl and tetrahydronaphthalen-methylsulfonamido compounds 195
Dual Inhibitors of Matrix Metalloproteinases and Carbonic Anhydrases: Iminodiacetyl-Based Hydroxamate-Benzenesulfonamide Conjugates 194
Ionic liquid-promoted green synthesis of biologically relevant diaryl thioethers 194
(Z)-(Methyloxyiminomethyl)ethanolamines. Effects of the configuration around the iminic double bond on the beta-adrenergic affinity of moim-type beta-adrenergic blocking agents 192
Novel Transthyretin Amyloid Fibril Formation Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural Analysis 192
Design, Synthesis, Biological Evaluation, and NMR Studies of a New Series of Arylsulfones As Selective and Potent Matrix Metalloproteinase-12 Inhibitors 191
Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors 191
Age-related macular degeneration: Current knowledge of zinc metalloproteinases involvement 191
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 190
Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors 189
Antioxidant quercetin 3-O-glycosylated plant flavonols contribute to Transthyretin stabilization 188
SYNTHESIS, ANTIINFLAMMATORY ACTIVITY AND MOLECULAR-ORBITAL STUDIES OF A SERIES OF BENZYLIDENEAMINOXYPROPIONIC ACIDS SUBSTITUTED ON THE PHENYL RING 188
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity 188
A new D2 dopamine receptor agonist allosterically modulates A2A adenosine receptor signalling by interacting with the A2A/D2 receptor heteromer 187
Conformationally restrained ß-blocking oxime ethers. 2. Synthesis and ß-adrenergic properties of diastereoisomeric anti and syn 2-(5’-(3’-aryl-substituted)isoxazolidinyl)-N-alkylethanolamines 186
Synthesis and ß-adrenergic properties of (E)-N-[3-(alkylamino)-2- hydroxypropilidene](methyloxy)amines substituted with an aromatic group on their [(methyloxy)imino]methyl moiety (MOIMM): an investigation into the biopharmacological effects of an aryl substitution in the class of MOIM ß-blocking drugs. 185
Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides 185
Synthesis of New Classes of MMPs Sugars-Based Inhibitors 184
Synthetic MMP Inhibitors: Slow-Binding Behaviour of Enantioselective N-O-Sulfonamido Based Inhibitors Directed to Specific Matrixins 183
Matrix metalloproteinase inhibitors prevent the release and proteolytic activity of monocyte/macrophage-derived microparticles 183
N-O-Isopropyl sulfonamido-based hydroxamates: Kinetic characterisation of a series of MMP-12/MMP-13 dual target inhibitors 182
Selective Arylsulfonamide Inhibitors of ADAM-17: Hit Optimization and Activity in Ovarian Cancer Cell Models 182
Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP) 182
New bifunctional metalloproteinase inhibitors: an integrated approach towards biological improvements and cancer therapy. 181
2-(Methyleneaminoxy)methylmorpholine derivatives. Synthesis and antidepressant activity 178
N-O-Isopropyl Sulfonamido-Based Hydroxamates: Design, Synthesis and Biological Evaluation of Selective Matrix Metalloproteinase-13 Inhibitors as Potential Therapeutic Agents for Osteoarthritis 178
Conformationally restrained β -blocking oxime ethers: synthesis and β -adrenergic properties of diastereoisomeric anti and syn 2-(5-isoxazolidinyl)ethanolamines 178
Drug design of sulfonylated MMP inhibitors 177
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 177
Potent Arylsulfonamide Inhibitors of Tumor Necrosis Factor-a Converting Enzyme Able to Reduce Activated Leukocyte Cell Adhesion Molecule Shedding in Cancer Cell Models 177
Synthetic analogs of xanthohumol for use in the prevention and​/or treatment of tumors 177
Exploring the binding of quercetin-3-O-metabolites with transthyretin 177
Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors 177
Synthesis and antimicrobial activity of 7ß-(S) and 7ß-(R)-3-(methyleneaminoxy)-2-methylpropionamido substituted cephalosporanic acid derivatives 175
New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2) 175
Synthesis and adrenergic ß-blocking activity of (oxypropanolamino)-substituted [(benzylideneamino)oxy]propanolamines 175
ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion 175
1-(1-pirril)-3- ammino-2-propanoli N-sostituiti: sintesi e proprietà ß-adrenergiche 173
Synthesis and aldose reductase inhibitory activity of N-(arylsulfonyl)- and N-(aroyl)-N-(arylmethyloxy)glycines 173
A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs 172
Crystallization of bi-functional ligand protein complexes 171
Aryl-sulphonamidic dimers as metalloproteases inhibitors 170
Synthesis and β-adrenergic properties of tetrahydronaphthalene analogs of dichloroisoproterenol 170
Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition 169
Synthesis and ß-Adrenergic Properties Of (Z)-N-[3-(Alkylamino)-2-hydroxypropilidene](aryl-methyloxy)amines: Effects Of The Configuration Around The Methyloxyiminomethyl(MOIM) Double Bond On The Biopharmacological Properties Of MOIM-type ß-Blocking Agents 169
Immobilization of matrix metalloproteinase 8 (MMP-8) for online drug screening 169
Bacterial Zinc Metalloenzyme Inhibitors: Recent Advances and Future Perspectives 168
New spiromorpholone- and spiromorpholine-benzopyrane derivatives as potential activators of mito-KATP channel 168
Arylsulfonamide derivatives as metalloproteases inhibitors and their preparation, pharmaceutical compositions and use in the treatment of degenerative disorders 168
1-benzilossiimmino-3- ammino-2-propanoli: sintesi e proprietà ß-adrenergiche 167
Analysis of Human Carbonic Anhydrase II: Docking Reliability and Receptor-Based 3D-QSAR Study 167
Inhibitors of A Disintegrin And Metalloproteinases-10 reduce Hodgkin lymphoma cell growth in 3D microenvironments and enhance brentuximab-vedotin effect 167
In Vivo Imaging of Matrix Metalloproteinase 12 and Matrix Metalloproteinase 13 Activities in the Mouse Model of Collagen-Induced Arthritis 165
Compounds with a benzo [a]carbazole structure for use in the prevention and/or treatment of infectious diseases 164
Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors 164
alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: Enantioselective synthesis and selective inhibition of MMPs 164
Role of the benzylic hydroxyl group of adrenergic catecholamines in eliciting a-adrenergic activity. Synthesis and a1- and a2-adrenergic activity of 3-phenyl-3-piperidinols and of their desoxy analogs 164
Conversion reactions of cepham into penam systems. A route to determine the relative configurations of two diastereoisomeric 3-bromo-4-methoxycepham derivatives 163
Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues 163
Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors 161
Iminodiacetyl-monohydroxamate derivatives as potent and selective MMP inhibitors 160
Design of selective collagenase 3 (MMP-13) inhibitors as potential therapeutic agents in rheumatoid arthritis 160
Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models 158
MMP-8 Is Critical for Dexamethasone Therapy in Alkali-Burned Corneas Under Dry Eye Conditions 158
Synthesis and adrenergic beta-blocking activity of ortho-, meta- and para-oxypropanolamino-substituted [(benzylideneamino)oxy]propanolamines. 157
Sintesi, configurazione e proprietà ß-adrenergiche di derivati 1-(5-isossazolidin) 2-amminoetanolici diastereoisomeri 156
(E)-(ARYLMETHYLENEAMINOXY)ACETAMIDES AS ANALOGS OF NEUROLEPTIC BENZAMIDES - SYNTHESIS AND D-2-DOPAMINERGIC BINDING-AFFINITY 156
Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity 156
Omega-3 PUFAs as a Dietary Supplement in Senile Systemic Amyloidosis 155
New hydroxypyrimidinones as inhibitors of matrix metalloproteinases 155
Powerful twin carboxylic inhibitors for MMP homodimerization 155
Multitemplate Alignment Method for the Development of a Reliable 3D-QSAR Model for the Analysis of MMP3 Inhibitors 154
New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer's Disease 153
N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP 153
SYNTHESIS, PLATELET ANTI-AGGREGATING ACTIVITY AND ANTIINFLAMMATORY ACTIVITY OF A SERIES OF BETA-AMINOXYPROPIONIC ACIDS 152
3-(4-iodomethyl-2-oxo-1-azetidinyl)propynoic acid t-butyl ester: A new ß-lactam derivative. Synthesis of an ynamide by reaction of 4-iodomethylazetidin-2-one with the t-butyl ester of propiolic acid in the presence of copper (I) 152
Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma 152
Design, synthesis, biological evaluation and NMR studies of a new series of arylsulfones as selective and potent MMP-12 inhibitors 151
Totale 19.182
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.299
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021314 0 0 0 0 0 0 0 0 0 0 0 314
2021/20222.803 65 263 49 144 506 377 66 140 94 77 166 856
2022/20233.731 456 444 254 401 411 466 38 269 649 22 266 55
2023/20242.564 326 279 297 161 369 477 102 89 42 47 142 233
2024/20257.862 39 328 162 443 768 693 787 468 757 1.018 782 1.617
2025/202610.028 774 2.358 1.095 736 817 820 1.373 394 509 762 296 94
Totale 39.919